Sequence and expression of NAPIr is conserved among group A streptococci isolated from patients with acute poststreptococcal glomerulonephritis (APSGN) and non-APSGN

Journal of Nephrology

Volumn 20, Issue 3, 2007, Pages 364-369

  Fujino, Masayuki ^a,b   Yamakami, Kazuo ^a   Oda, Takashi ^a   Omasu, Fumihiro ^a   Murai, Teiko ^c   Yoshizawa, Nobuyuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Acute poststreptococcal glomerulonephritis; Amino acid sequence; Group A streptococcus; Nephritis associated plasmin receptor; Nucleotide sequence

Indexed keywords

MONOCLONAL ANTIBODY; NEPHRITIS ASSOCIATED PLASMIN RECEPTOR; NEPHRITOGENIC ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; CELL SURFACE RECEPTOR; NEPHRITIS ASSOCIATED PLASMINOGEN RECEPTOR, STREPTOCOCCUS; NEPHRITIS-ASSOCIATED PLASMINOGEN RECEPTOR, STREPTOCOCCUS;

ACUTE GLOMERULONEPHRITIS; ALLERGIC GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARYNGITIS; PROTEIN EXPRESSION; SCARLET FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; BIOSYNTHESIS; GENETICS; GLOMERULONEPHRITIS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTIGENS, BACTERIAL; GLOMERULONEPHRITIS; HUMANS; RECEPTORS, CELL SURFACE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 35348861880     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
2. White AV, Hoy WE, McCredie DA. Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life. Med J Aust 2001; 174: 492-6.
3. Yoshizawa N. Acute glomerulonephritis. Intern Med 2000; 39: 687-94.
4. Welfle K, Misselwitz R, Schaup A, Gerlach D, Welfle H. Conformation and stability of streptokinases from nephritogenic and nonnephritogenic strains of streptococci. Proteins 1997; 27: 26-35.
5. Yamakami K, Yoshizawa N, Wakabayashl K, Takeuchi A, Tadakuma T, Boyle MD. The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods 2000; 21: 185-97.
6. Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MD. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol 2004; 15: 1785-93.
7. Oda T, Yamakami K, Omasu F, Suzuki S, Miura S, Sugisaki T, Yoshizawa N. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol 2005; 16: 247-54.
8. Lottenberg R, Broder CC, Boyle MD, Kain SJ, Schroeder BL, Curtiss R 3rd. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 1992; 174: 5204-10.
9. Winram SB, Lottenberg R. The plasmin-binding protein PIr of group A Streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology 1996; 142: 2311-20.
10. McKay FC, McArthur JD. Sanderson-Smith ML, Gardam S, Currie BJ, Sriprakash KS, Fagan PK, Towers RJ, Batzloff MR, Chhatwal GS, Ranson M, Walker MJ. Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun 2004; 72: 364-70.
11. Boel G, Jin H, Pancholi V. Inhibition of cell surface export of group A streptococcal anchorless surface dehydrogenase affects bacterial adherence and antiphagocytic properties. Infect Immun 2005; 73: 6237-48.
12. Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, Dou SJ, Pan X, Nakashima K, Musser JM. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 2001; 183: 633-9.
13. Batsford SR, Mezzano S, Mihatsch M, Schiltz E, Rodriguez-Iturbe B. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 2005; 68: 1120-9.
14. Abdel-Rehim M, Degnan B, El-Ghobary A, Hart A, El-Sayed H, El-Sheikh N, Goodacre J. Serum antibodies to group A streptococcal extracellular and cell-associated antigens in Egyptians with post-streptococcal diseases. FEMS Immunol Med Microbiol 2001; 31: 21-7.
15. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 2002; 185: 1586-95.
16. Kreikemeyer B, McIver KS, Podbielski A. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol 2003; 11: 224-32.
17. Efstratiou A. Pyogenic streptococci of Lancefield groups C and G as pathogens in man. Soc Appl Bacteriol Symp Ser 1997; 26: 72S-9S.
18. Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemics (Lancefield group C). Lancet 1983; 1: 945-8.
19. Reid HF, Bassett DC, Poon-King T, Zabriskie JB, Read SE. Group G streptococci in healthy school-children and in patients with glomerulonephritis in Trinidad. J Hyg (Lond) 1985; 94: 61-8.